{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:50:58Z","timestamp":1788875458383,"version":"build-2803163510"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T00:00:00Z","timestamp":1650844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Multiple sclerosis (MS) is an incurable and progressive neurodegenerative disease that affects more than 2.5 million people worldwide and brings tremendous economic pressures to society. However, the pathophysiology of MS is still not fully elucidated, and there is no effective treatment. Demyelination is thought to be the primary pathophysiological alteration in MS, and our previous study found abnormal lipid metabolism in the demyelinated corpus callosum. Growing evidence indicates that central nervous system (CNS) demyelinating diseases never result from one independent factor, and the simultaneous participation of abnormal lipid metabolism, oxidative stress, and neuroinflammation could potentiate each other in the pathogenesis of MS. Therefore, a single omics analysis cannot provide a full description of any neurodegenerative disease. It has been demonstrated that oxidative stress and neuroinflammation are two reciprocal causative reasons for the progression of MS disease. However, the potential crosstalk between oxidative stress and neuroinflammation remains elusive so far. With an integrated analysis of targeted lipidomics and transcriptomics, our research presents the potential interaction between abnormalities of lipid metabolism, mitochondrial dysfunction, oxidative stress, and neuroinflammation in CNS demyelinating diseases. The findings of this paper may be used to identify possible targets for the therapy of CNS demyelinating diseases.<\/jats:p>","DOI":"10.3389\/fnagi.2022.870957","type":"journal-article","created":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T09:32:40Z","timestamp":1650879160000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":63,"title":["Integrating Lipidomics and Transcriptomics Reveals the Crosstalk Between Oxidative Stress and Neuroinflammation in Central Nervous System Demyelination"],"prefix":"10.3389","volume":"14","author":[{"given":"Zhi-jie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-zhe","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-hua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,4,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.bbadis.2011.01.012","article-title":"Analysis of the mitochondrial proteome in multiple sclerosis cortex.","volume":"1812","author":"Broadwater","year":"2011","journal-title":"Biochim Biophys Acta."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/1873-3468.13013","article-title":"Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis.","volume":"592","author":"Campbell","year":"2018","journal-title":"FEBS Lett."},{"key":"B3","doi-asserted-by":"publisher","first-page":"8481","DOI":"10.1128\/JVI.00533-13","article-title":"Activity increase in respiratory chain complexes by rubella virus with marginal induction of oxidative stress.","volume":"87","author":"Claus","year":"2013","journal-title":"J. Virol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1056\/NEJMra022567","article-title":"Mitochondrial respiratory-chain diseases.","volume":"348","author":"DiMauro","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/nrneurol.2013.126","article-title":"The clinical maze of mitochondrial neurology.","volume":"9","author":"DiMauro","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.clinph.2021.07.020","article-title":"Lateral spread response of different facial muscles during microvascular decompression in hemifacial spasm.","volume":"132","author":"Kim","year":"2021","journal-title":"Clin. Neurophysiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","article-title":"Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.","volume":"443","author":"Lin","year":"2006","journal-title":"Nature"},{"key":"B8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0022-510x(00)00343-9","article-title":"Oxidative damage to mitochondrial dna and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis.","volume":"177","author":"Lu","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fnana.2020.00030","article-title":"Differential susceptibility and vulnerability of brain cells in c57bl\/6 mouse to mitochondrial dysfunction induced by short-term cuprizone exposure.","volume":"14","author":"Luo","year":"2020","journal-title":"Front. Neuroanat."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/brain\/awp046","article-title":"Mitochondrial changes within axons in multiple sclerosis.","volume":"132","author":"Mahad","year":"2009","journal-title":"Brain"},{"key":"B11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nbd.2018.01.002","article-title":"Microglial activation and the nitric oxide\/cgmp\/pkg pathway underlie enhanced neuronal vulnerability to mitochondrial dysfunction in experimental multiple sclerosis.","volume":"113","author":"Mancini","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bbadis.2009.07.002","article-title":"Is multiple sclerosis a mitochondrial disease?","volume":"1802","author":"Mao","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108181","article-title":"Antagonizing astrocytic platelet activating factor receptor-neuroinflammation for total flavone of epimedium in response to cuprizone demyelination.","volume":"101","author":"Meng-Ru","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22137183","article-title":"Effects of venlafaxine, risperidone and febuxostat on cuprizone-induced demyelination, behavioral deficits and oxidative stress.","volume":"22","author":"Mihai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20204975","article-title":"Assessment of mitochondrial dysfunction in experimental autoimmune encephalomyelitis (eae) models of multiple sclerosis.","volume":"20","author":"Ng","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1016\/s1357-2725(02)00077-8","article-title":"Mitochondrial function and dysfunction in the cell: its relevance to aging and aging-related disease.","volume":"34","author":"Nicholls","year":"2002","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nm.2324","article-title":"A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis.","volume":"17","author":"Nikic","year":"2011","journal-title":"Nat. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s10495-007-0756-2","article-title":"Mitochondria, oxidative stress and cell death.","volume":"12","author":"Ott","year":"2007","journal-title":"Apoptosis"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/srep33249","article-title":"Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis.","volume":"6","author":"Sadeghian","year":"2016","journal-title":"Sci. Rep."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22263-4","article-title":"Overcoming the inhibitory microenvironment surrounding oligodendrocyte progenitor cells following experimental demyelination.","volume":"12","author":"Saraswat","year":"2021","journal-title":"Nat. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neubiorev.2019.08.008","article-title":"Behavioural phenotypes in the cuprizone model of central nervous system demyelination.","volume":"107","author":"Sen","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105534","article-title":"Trpm2 contributes to neuroinflammation and cognitive deficits in a cuprizone-induced multiple sclerosis model via nlrp3 inflammasome.","volume":"160","author":"Shao","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s10571-020-00910-6","article-title":"Mesenchymal stem cells ameliorate cuprizone-induced demyelination by targeting oxidative stress and mitochondrial dysfunction.","volume":"41","author":"Shiri","year":"2020","journal-title":"Cell. Mol. Neurobiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1093\/brain\/awu139","article-title":"Cerebrospinal fluid ceramides from patients with multiple sclerosis impair neuronal bioenergetics.","volume":"137","author":"Vidaurre","year":"2014","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119842","article-title":"Cuprizone-induced oligodendrocyte loss and demyelination impairs recording performance of chronically implanted neural interfaces.","volume":"239","author":"Wellman","year":"2020","journal-title":"Biomaterials"},{"key":"B26","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.molmed.2013.11.007","article-title":"Mitochondrial dysfunction contributes to neurodegeneration in multiple sclerosis.","volume":"20","author":"Witte","year":"2014","journal-title":"Trends Mol. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1089\/ars.2019.7952","article-title":"Reactive oxygen species and their impact in neurodegenerative diseases: literature landscape analysis.","volume":"34","author":"Yeung","year":"2021","journal-title":"Antioxid Redox Signal."},{"key":"B28","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s11427-019-9821-2","article-title":"Phloroglucinol derivative compound 21 attenuates cuprizone-induced multiple sclerosis mice through promoting remyelination and inhibiting neuroinflammation.","volume":"63","author":"Zhao","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7093844","article-title":"Untargeted metabolomic profiling of cuprizone-induced demyelination in mouse corpus callosum by uplc-orbitrap\/ms reveals potential metabolic biomarkers of cns demyelination disorders.","volume":"2021","author":"Zhao","year":"2021","journal-title":"Oxid Med. Cell Longev."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.870957\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T09:32:43Z","timestamp":1650879163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2022.870957\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,25]]},"references-count":29,"alternative-id":["10.3389\/fnagi.2022.870957"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2022.870957","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,25]]},"article-number":"870957"}}